Endovascular Laser Treatment of Varicose Veins



Endovascular Laser Treatment of Varicose Veins



Nick Morrison


Since 2001, endovenous laser ablation procedures have been reported to be safe and effective methods of eliminating the proximal portion of the greater saphenous vein (GSV), the small saphenous vein (SSV), and even tributary and perforator veins from the venous circulation, with faster recovery and better cosmetic results than traditional surgical ligations and stripping. Lasers of varying wavelengths deliver light energy to the vein through an indwelling fiber, which results in direct or indirect damage to the vein wall intended to result in sclerosis and ultimately resorption of the vein. As with traditional surgical treatment of incompetent saphenous veins, when following these endovenous laser ablation procedures it is necessary to treat any remaining incompetent portion of the GSV or SSV, persistent incompetent perforator veins, and varicose tributaries, typically with sclerotherapy and/or phlebectomy.


The first generation of endovenous lasers used wavelengths (800–1000 nm) that targeted hemoglobin as the chromophore. Newer, longer-wavelength lasers (1300–1600 nm) target water and thus the endothelial cell wall. Original reports of endovenous laser ablation described the use of pulsed laser energy. Because of patient reports of painful bruising secondary to vein wall perforations with the pulsed mode, the technique was altered to continuously applied delivery.


Lasers of higher wavelength targeting water in the vein wall with lower power settings has seemed to significantly lessen discomfort by causing fewer perforations and perivenous bleeding, the presumed cause of the pain. Reports of randomized comparative clinical trials have established better patient outcomes with higher-wavelength lasers than lower-wavelength lasers. Just as laser generators have evolved, the original 600-μm bare-tipped fibers have evolved to covered and radial fibers and centering devices, all designed to limit the risk of vein wall perforation and to more evenly distribute endothelial thermal injury.



Patient Selection


Clinical indications for laser therapy have been established (Box 1). Absolute contraindications for this form of venoablation include restricted patient mobility, acute deep or superficial vein thrombosis, significantly impaired deep venous outflow, and any active infectious process. Relative contraindications, including arteriovenous malformations, hypercoagulable states, sclerotic or tortuous veins, and large or aneurysmal veins can be safely ignored as one gains experience with the laser ablation technique.



Strong consideration of thrombophilia should be given preoperatively to patients with a history of deep vein thrombosis (DVT), recurrent episodes of acute superficial thrombophlebitis, multiple spontaneous abortions, or strong family history of DVT or clotting disorders. The physician should be aware of the American College of Chest Physicians guidelines for risk assessment for DVT, because they may be helpful in choosing which patients should receive prophylactic anticoagulation before undergoing endovenous laser ablation. Although the risk of DVT following these procedures is low (<1%), such a potentially life-threatening outcome following treatment of relatively benign disease could be catastrophic.


Duplex ultrasound (US) is integral to an accurate diagnosis for appropriate patient selection. However, several factors have resulted in the frustration of inconsistent duplex reports. Duplex examination is operator dependent, and training in superficial venous disorders has only very recently improved somewhat. The complexity of venous hemodynamics has not been previously well understood or appreciated. Finally, there is considerable inconsistency in the sensitivity of duplex equipment, which hampers identification of lower level reflux in some symptomatic patients, leading to inadequate diagnosis and treatment. In an attempt to explain one of the causes of inconsistent duplex reports, the author a study was conducted by a colleague to gauge the effect of the sensitivity of different US machines. One can see that in comparing the most sensitive equipment (“D”) with the least sensitive equipment (“E”), agreement was present only two thirds of the time. It is therefore apparent that reflux can be missed in more than one third of patients if the least sensitive equipment is used.



Technique


Endovenous laser ablation was initially performed in the operating room or radiology suite using conscious sedation or general anesthesia, but most procedures can now be safely performed under US guidance in the office setting under local anesthesia with or without sedation. The ablation procedure described for the GSV or SSV is similar to that for non-saphenous veins. Ligation of the saphenous vein near the deep venous junction, as advocated by some, is neither necessary nor desirable.


The patient is placed on an adjustable operating table with Trendelenburg capability. The course of the saphenous vein, from the saphenofemoral or saphenopopliteal junction to the insertion site, is mapped by US. An insertion site is chosen to maximize treatment length, minimize risk of thermal damage to perivenous structures, and ensure facile access. Most physicians use a site in the distal thigh or proximal calf for the great saphenous vein and the mid to distal calf for the small saphenous vein. Given extensive US-guided experience, some advocate treatment of the entire length of incompetent vein with little or no increased risk of paresthesia from thermal injury to perivenous nerves.


Access to the target vein is most often gained using an ultrasound-guided percutaneously placed needle followed by a guidewire, as in the Seldinger technique. Maneuvers such as placing the patient in a semierect position or applying 2% topical nitroglycerin ointment (Nitropaste) to the proposed insertion site before the sterile surgical prep can enhance successful venous cannulation by dilating the vein and preventing venospasm. It is sometimes appropriate to choose a primary access site and a higher, larger-diameter secondary (backup) access site in case access at the primary site is unsuccessful. As the practitioner’s US technical skills improve, even small-diameter saphenous veins can be successfully cannulated.


The first attempt at cannulation of the vein is the most likely to be successful, so the insertion site should be carefully chosen to make access as ergonomically feasible as possible. Just below the knee, the great saphenous vein is relatively anterior, and with the patient’s operative leg externally rotated, this site becomes more advantageous than in the distal or mid thigh.


After infiltration of local anesthetic at the insertion site, an introducer needle is inserted into the vein under US guidance. A microinsertion set can be used to gain access for the sheath that will accommodate a 600-μm laser fiber. Using the Seldinger technique and guidewire, the sheath is advanced into the vein over the guidewire until it is identified by US to be 3 to 4 cm below the saphenofemoral junction or just inferior to the deep penetration of the SSV where it joins the deep system. Alternatively, the bare-tipped fiber may be advanced directly through the access needle or the short sheath in the micropuncture set and carefully guided to the same position.


Occasionally, passage of the fiber is impeded by vein tortuosity. Straightening the leg or gently guiding the fiber by external compression and manipulation of the thigh usually allows successful advancement. Segmental stenosis from previous sclerotherapy or thrombophlebitis also impedes advancement of the fiber or guidewire. In this case, or if the vein is so tortuous as to not allow passage, a second cannulation allows treatment of first the proximal and then the distal segments of the saphenous vein.


US-guided dilute anesthesia (0.05%–0.25% lidocaine with epinephrine and bicarbonate) is then injected into the saphenous compartment (Figure 1), completely surrounding the target vein to ensure an adequate anesthetic effect. The tumescent local anesthetic causes the vein to become contracted for better thermal effect and to protect the perivenous structures from thermal damage. It is always necessary to clearly identify important anatomic landmarks (Figure 2) near the deep venous junction before injecting the local anesthetic, which will obscure these landmarks, severely limiting visualization of the correct position of the laser tip. The tumescence of the well placed anesthetic provides compression of the vein, which in turn limits the volume of blood within the vein which enhances the effect of the laser energy on the vein wall.


Stay updated, free articles. Join our Telegram channel

Aug 25, 2016 | Posted by in CARDIOLOGY | Comments Off on Endovascular Laser Treatment of Varicose Veins

Full access? Get Clinical Tree

Get Clinical Tree app for offline access